Vetanic
The startup develops induced pluripotent stem cell technology for veterinary regenerative medicine, utilizing adipose tissue-derived treatments without pathogenic viruses to maintain long-term pluripotency. This approach enhances canine health by providing effective regenerative therapies for conditions that currently lack adequate treatment options.
Traction –/10
Tokyo, Japan · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops induced pluripotent stem cell technology for veterinary regenerative medicine, utilizing adipose tissue-derived treatments without pathogenic viruses to maintain long-term pluripotency. This approach enhances canine health by providing effective regenerative therapies for conditions that currently lack adequate treatment options.